Drug
Polystyrene sulfonic acid clinical trials
Also written Sodium polystyrene sulfonate and Kayexalate.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 1992
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 1992 (1)
| Year | Studies |
|---|---|
| 1992 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2020 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 4
Alexandria University (1) · Maisonneuve-Rosemont Hospital (1) · National Center for Research Resources (NCRR) (1) · University of California, Irvine (1) · ZS Pharma, Inc. (1)
Often tested with
Tested in the same studies.
Sodium zirconium cyclosilicate (2) · Enalapril (1) · Polyethylene glycol 3350 (1) · Polyethylene Glycols (1) · Patiromer (1)
Studies
Open first, then newest update. How each study uses polystyrene sulfonic acid is read from its arms, and is right about nine times in ten.
Testing it · 5
- Comparison of Potassium Binders in the ERTerminatedPhase 4University of California, IrvineNCT04585542Written as Sodium Polystyrene Sulfonate Oral Suspension [SPS]
- SZC Versus SPS for Treatment of Hyperkalemia in Hemodialysis PatientsCompletedNot applicableAlexandria UniversityNCT06029179Written as sodium polystyrene sulfonate
- Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis PatientsCompletedPhase 4Maisonneuve-Rosemont HospitalNCT02065076Written as Sodium polystyrene sulfonate
- Safety and Efficacy of Sodium Polystyrene Sulfonate in HyperkalemiaTerminatedPhase 4ZS Pharma, Inc.NCT01866709Written as Sodium polystyrene sulfonate
- Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type ICompletedPhase 2National Center for Research Resources (NCRR)NCT00004328Written as polystyrene sulfonate
Codes
What other systems call polystyrene sulfonic acid · ClinicalTrials.gg INT002271
- MeSH (NLM) C003321polystyrene sulfonic acidConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 70KO0R01RYPOLYSTYRENE SULFONIC ACIDOne source NLM
- RxNorm 1546436One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C003321 | polystyrene sulfonic acid | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 70KO0R01RY | POLYSTYRENE SULFONIC ACID | One source NLM |
| RxNorm | 1546436 | — | One source FDA |
Also registered as calcium polystyrene sulfonate (UNII HUI2S00793 · RxNorm 47630) and sodium polystyrene sulfonate (UNII 1699G8679Z · RxNorm 56512).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.